By AMR, Incorporated

closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
seller: The Nielsen Company, Inc. (NLSN:$6,618.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,296.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2008 via PR Newswire

Quintiles Transnational Corp., will acquire Eidetics

synopsis: Quintiles Transnational Corp. announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. Our 23,000 employees in more than 50 countries have helped develop or commercialize all of the top 30 best-selling drugs. "
target: Eidetics
Eidetics is being acquired by Quintiles. A market research and consulting company serving the world's leading pharmaceutical, biotechnology, and medical device companies. Headquartered in Boston, we have extensive international resources to address the global nature of today's marketing challenges.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/22/2004 via PR Newswire

Ventiv Health, acquired HHI Clinical Research & Statistical Services, L.L.C.

synopsis: Ventiv Health, Inc. VTIV, a leading provider of late-stage clinical, sales, marketing and compliance services to pharmaceutical and biotech organizations, today announced that it has successfully completed the acquisition of HHI Clinical & Statistical Research Services, L.L.C.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: HHI Clinical Research & Statistical Services, L.L.C.
HHI Clinical Research & Statistical Services, L.L.C. is a focused clinical service provider managing statistical analysis and data management functions for pharmaceutical and biotechnology companies. HHI's services include data support, programming, statistical analysis and report writing. HHI has
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/16/2004 via PR Newswire

Thomson Scientific & Healthcare, acquired Newport Strategies, Inc.

synopsis: The Thomson Corporation announced that it has acquired Newport Strategies, Inc., a leading provider of competitive intelligence for the pharmaceutical industry. Newport Strategies will become part of the scientific business within the Thomson Scientific and Healthcare market group.
buyer parent: The Thomson Corporation
buyer: Thomson Scientific & Healthcare
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Newport Strategies, Inc.
Newport develops and markets cutting-edge systems that deliver the earliest and most reliable source of global intelligence on competition for launched pharmaceutical products. Innovator, generic and specialty pharmaceutical companies worldwide use Newport's systems and expert confidential consulti
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2005 via PR Newswire

Greenfield Online, Inc., acquired Rapidata.net, Inc.

synopsis: Greenfield Online, Inc SRVY, a leading provider of Internet survey solutions to marketing research and consulting companies, today announced it has completed the acquisition of Rapidata.net, Inc., a privately-held North Carolina corporation, for $5.5 million in cash, subject to certain post closing adjustments.
buyer: Greenfield Online, Inc. (SRVY:$0.00)
Greenfield Online, Inc. is a global interactive media and services company that collects consumer attitudes about products and services, enabling consumers to reach informed purchasing decisions about the products and services they want to buy; and helping companies better understand their customer."
target: Rapidata.net, Inc.
Founded fifteen years ago by research pharmacist and professor David P. Lipson, R.PH., Ph.D., Rapidata.net connects pharmaceutical market researchers to healthcare providers and their patients. This connection allows pharmaceutical market researchers to learn more about the prescription medications
price ($mm)
$5.50
rev ($mm)
$2
EBITDA ($mm)
EV / rev
2.6x
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/14/2009 via BusinessWire

Majestic Research, LLC, acquired Rood Research, Inc.

synopsis: Majestic Research, a global, independent equity research company and a pioneer in data driven analysis, announced its acquisition of New York-based Rood Research – a leading provider of healthcare market research.
buyer: Majestic Research, LLC
Since its inception in 2002, Majestic Research has revolutionized the financial research business with our innovative proprietary methods and tools for accessing real-time data. "
target: Rood Research, Inc.
In the past 15 years, Rood Research has become a leader in providing healthcare research to some of the top pharmaceutical and biotech companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2008 via BusinessWire

Surveillance Data, Inc., acquired Verispan, LLC

synopsis: SDI, the leader in innovative healthcare analytics, has acquired Verispan, a top provider of healthcare information and services. The acquisition creates the healthcare industry’s most comprehensive de-identified longitudinal database.
buyer parent: LLR Partners
buyer: Surveillance Data, Inc.
SDI provides a wide range of healthcare data and market research to pharmaceutical, consumer products, and healthcare-related companies. Since 1981, SDI's mission has been to provide healthcare data products with high business relevance as well as the means and know-how to put this data into action."
target: Verispan, LLC
Verispan provides a broad array of information products and services to virtually all of the top 50 pharmaceutical companies and the healthcare industry in general, including sales targeting and compensation products; market research audits; healthcare profiles; and direct mail, among many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/16/2018 via Company Press Release

Vestar Capital Partners, will acquire Information Resources, Inc.

synopsis: Vestar Capital Partners, a private equity firm, will lead a new investment in Information Resources, Inc., a leading provider of big data, predictive analytics and forward-looking insights. Jeffrey Ansell, a Vestar Senior Advisor, will serve as Chairman of IRI. New Mountain and other existing investors are retaining a meaningful investment in IRI.
buyer: Vestar Capital Partners
Vestar Capital Partners (VCP) is a private equity firm specializing in management buyouts and growth capital investments. VCP collaborates with management teams and private owners to build long- term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products."
target parent: New Mountain Capital, LLC
target: Information Resources, Inc.
Information Resources, Inc. is a leading provider of big data, predictive analytics and forward-looking insights that help CPG companies, OTC health care organizations, retailers, financial services and media companies grow their businesses.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2018 via Company Press Release

BioInformatics Inc., acquired Kalorama Information

synopsis: BioInformatics Inc., the premier research and advisory company serving the life science industry, has acquired Kalorama Information from MarketResearch. Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics, imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target parent: MarketResearch.com, Inc.
target: Kalorama Information
Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals. Kalorama only publishes in healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Health Strategies Group

synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Health Strategies Group. Health Strategies Group is the leader in market access intelligence and customized research for pharmaceutical and biotech professionals. It dissects trends and identifies opportunities to help companies optimize their product access.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target: Health Strategies Group
Health Strategies Group offers a dedicated team of research leaders committed to dissecting the trends, identifying customer needs, and pinpointing the barriers and opportunities for biopharma within the evolving health care environment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2015 via PR Newswire

Insignia Capital Group, acquired Metanexgen, Inc.

synopsis: Insignia Capital Group announced the acquisition of metanexgen from DFW Capital Partners. Based in Bensalem, PA, metanexgen is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners.
buyer: Insignia Capital Group
Insignia Capital is a private equity firm working with lower-middle market companies. Insignia Capital works with a wide variety of companies but their specialty is consumer, business services and healthcare. "
target parent: DFW Capital Partners
target: Metanexgen, Inc.
Metanexgen is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/12/2014 via Company Press Release

Everyday Health, Inc., will acquire DoctorDirectory.com

synopsis: Everyday Health signed a definitive agreement to acquire DoctorDirectory. Based in North Carolina, DoctorDirectory provides pharmaceutical companies with multi-channel marketing services that target healthcare professionals. DoctorDirectory.com, Inc. also operates as an online directory for finding a doctor by specialty.
buyer: Everyday Health, Inc. (EVDY:$253.92)
Everyday Health, Inc. is a provider of digital health and wellness solutions. They attract consumers and healthcare professionals to their health and wellness properties, and utilize their data and analytics to deliver personalized content experiences and marketing and engagement solutions. "
target: DoctorDirectory.com
DoctorDirectory.com, Inc. operates as an online directory for finding a doctor by specialty. They also provide Healthcare Professionals the opportunity to participate in Market Research and other programs that help shape the healthcare industry.
price ($mm)
$65
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
seller: The Nielsen Company, Inc. (NLSN:$6,618.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,296.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2008 via PR Newswire

Quintiles Transnational Corp., will acquire Eidetics

synopsis: Quintiles Transnational Corp. announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. Our 23,000 employees in more than 50 countries have helped develop or commercialize all of the top 30 best-selling drugs. "
target: Eidetics
Eidetics is being acquired by Quintiles. A market research and consulting company serving the world's leading pharmaceutical, biotechnology, and medical device companies. Headquartered in Boston, we have extensive international resources to address the global nature of today's marketing challenges.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/22/2004 via PR Newswire

Ventiv Health, acquired HHI Clinical Research & Statistical Services, L.L.C.

synopsis: Ventiv Health, Inc. VTIV, a leading provider of late-stage clinical, sales, marketing and compliance services to pharmaceutical and biotech organizations, today announced that it has successfully completed the acquisition of HHI Clinical & Statistical Research Services, L.L.C.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: HHI Clinical Research & Statistical Services, L.L.C.
HHI Clinical Research & Statistical Services, L.L.C. is a focused clinical service provider managing statistical analysis and data management functions for pharmaceutical and biotechnology companies. HHI's services include data support, programming, statistical analysis and report writing. HHI has
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/16/2004 via PR Newswire

Thomson Scientific & Healthcare, acquired Newport Strategies, Inc.

synopsis: The Thomson Corporation announced that it has acquired Newport Strategies, Inc., a leading provider of competitive intelligence for the pharmaceutical industry. Newport Strategies will become part of the scientific business within the Thomson Scientific and Healthcare market group.
buyer parent: The Thomson Corporation
buyer: Thomson Scientific & Healthcare
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Newport Strategies, Inc.
Newport develops and markets cutting-edge systems that deliver the earliest and most reliable source of global intelligence on competition for launched pharmaceutical products. Innovator, generic and specialty pharmaceutical companies worldwide use Newport's systems and expert confidential consulti
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2005 via PR Newswire

Greenfield Online, Inc., acquired Rapidata.net, Inc.

synopsis: Greenfield Online, Inc SRVY, a leading provider of Internet survey solutions to marketing research and consulting companies, today announced it has completed the acquisition of Rapidata.net, Inc., a privately-held North Carolina corporation, for $5.5 million in cash, subject to certain post closing adjustments.
buyer: Greenfield Online, Inc. (SRVY:$0.00)
Greenfield Online, Inc. is a global interactive media and services company that collects consumer attitudes about products and services, enabling consumers to reach informed purchasing decisions about the products and services they want to buy; and helping companies better understand their customer."
target: Rapidata.net, Inc.
Founded fifteen years ago by research pharmacist and professor David P. Lipson, R.PH., Ph.D., Rapidata.net connects pharmaceutical market researchers to healthcare providers and their patients. This connection allows pharmaceutical market researchers to learn more about the prescription medications
price ($mm)
$5.50
rev ($mm)
$2
EBITDA ($mm)
EV / rev
2.6x
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/14/2009 via BusinessWire

Majestic Research, LLC, acquired Rood Research, Inc.

synopsis: Majestic Research, a global, independent equity research company and a pioneer in data driven analysis, announced its acquisition of New York-based Rood Research – a leading provider of healthcare market research.
buyer: Majestic Research, LLC
Since its inception in 2002, Majestic Research has revolutionized the financial research business with our innovative proprietary methods and tools for accessing real-time data. "
target: Rood Research, Inc.
In the past 15 years, Rood Research has become a leader in providing healthcare research to some of the top pharmaceutical and biotech companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2008 via BusinessWire

Surveillance Data, Inc., acquired Verispan, LLC

synopsis: SDI, the leader in innovative healthcare analytics, has acquired Verispan, a top provider of healthcare information and services. The acquisition creates the healthcare industry’s most comprehensive de-identified longitudinal database.
buyer parent: LLR Partners
buyer: Surveillance Data, Inc.
SDI provides a wide range of healthcare data and market research to pharmaceutical, consumer products, and healthcare-related companies. Since 1981, SDI's mission has been to provide healthcare data products with high business relevance as well as the means and know-how to put this data into action."
target: Verispan, LLC
Verispan provides a broad array of information products and services to virtually all of the top 50 pharmaceutical companies and the healthcare industry in general, including sales targeting and compensation products; market research audits; healthcare profiles; and direct mail, among many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/16/2018 via Company Press Release

Vestar Capital Partners, will acquire Information Resources, Inc.

synopsis: Vestar Capital Partners, a private equity firm, will lead a new investment in Information Resources, Inc., a leading provider of big data, predictive analytics and forward-looking insights. Jeffrey Ansell, a Vestar Senior Advisor, will serve as Chairman of IRI. New Mountain and other existing investors are retaining a meaningful investment in IRI.
buyer: Vestar Capital Partners
Vestar Capital Partners (VCP) is a private equity firm specializing in management buyouts and growth capital investments. VCP collaborates with management teams and private owners to build long- term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products."
target parent: New Mountain Capital, LLC
target: Information Resources, Inc.
Information Resources, Inc. is a leading provider of big data, predictive analytics and forward-looking insights that help CPG companies, OTC health care organizations, retailers, financial services and media companies grow their businesses.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2018 via Company Press Release

BioInformatics Inc., acquired Kalorama Information

synopsis: BioInformatics Inc., the premier research and advisory company serving the life science industry, has acquired Kalorama Information from MarketResearch. Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics, imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target parent: MarketResearch.com, Inc.
target: Kalorama Information
Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals. Kalorama only publishes in healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Health Strategies Group

synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Health Strategies Group. Health Strategies Group is the leader in market access intelligence and customized research for pharmaceutical and biotech professionals. It dissects trends and identifies opportunities to help companies optimize their product access.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target: Health Strategies Group
Health Strategies Group offers a dedicated team of research leaders committed to dissecting the trends, identifying customer needs, and pinpointing the barriers and opportunities for biopharma within the evolving health care environment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2015 via PR Newswire

Insignia Capital Group, acquired Metanexgen, Inc.

synopsis: Insignia Capital Group announced the acquisition of metanexgen from DFW Capital Partners. Based in Bensalem, PA, metanexgen is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners.
buyer: Insignia Capital Group
Insignia Capital is a private equity firm working with lower-middle market companies. Insignia Capital works with a wide variety of companies but their specialty is consumer, business services and healthcare. "
target parent: DFW Capital Partners
target: Metanexgen, Inc.
Metanexgen is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/12/2014 via Company Press Release

Everyday Health, Inc., will acquire DoctorDirectory.com

synopsis: Everyday Health signed a definitive agreement to acquire DoctorDirectory. Based in North Carolina, DoctorDirectory provides pharmaceutical companies with multi-channel marketing services that target healthcare professionals. DoctorDirectory.com, Inc. also operates as an online directory for finding a doctor by specialty.
buyer: Everyday Health, Inc. (EVDY:$253.92)
Everyday Health, Inc. is a provider of digital health and wellness solutions. They attract consumers and healthcare professionals to their health and wellness properties, and utilize their data and analytics to deliver personalized content experiences and marketing and engagement solutions. "
target: DoctorDirectory.com
DoctorDirectory.com, Inc. operates as an online directory for finding a doctor by specialty. They also provide Healthcare Professionals the opportunity to participate in Market Research and other programs that help shape the healthcare industry.
price ($mm)
$65
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

By AMR, Incorporated


read more

Arlington Medical Resources Inc.

read more

The Nielsen Company, Inc.

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

SDI Health LLC

InforMed Direct

BioTrends Research Group, Inc.

Eidetics

Arlington Medical Resources Inc.

HHI Clinical Research & Statistical Services, L.L.C.

Newport Strategies, Inc.

Rapidata.net, Inc.

Double Helix

Rood Research, Inc.

Verispan, LLC

Information Resources, Inc.

Kalorama Information

Health Strategies Group

Metanexgen, Inc.

DoctorDirectory.com

read more

The Nielsen Company, Inc.

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

SDI Health LLC

InforMed Direct

BioTrends Research Group, Inc.

Eidetics

Arlington Medical Resources Inc.

HHI Clinical Research & Statistical Services, L.L.C.

Newport Strategies, Inc.

Rapidata.net, Inc.

Double Helix

Rood Research, Inc.

Verispan, LLC

Information Resources, Inc.

Kalorama Information

Health Strategies Group

Metanexgen, Inc.

DoctorDirectory.com

Geography
Matching Companies